Xencor

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.

About XNCR

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.

CEO

Bassil I. Dahiyat

CEOBassil I. Dahiyat

Employees

250

Employees250

Headquarters

Pasadena, California

HeadquartersPasadena, California

Founded

1997

Founded1997

Employees

250

Employees250

XNCR Key Statistics

Market cap

603.29M

Market cap603.29M

Price-Earnings ratio

-3.48

Price-Earnings ratio-3.48

Dividend yield

—

Dividend yield—

Average volume

804.72K

Average volume804.72K

High today

$8.57

High today$8.57

Low today

$8.29

Low today$8.29

Open price

$8.52

Open price$8.52

Volume

655.85K

Volume655.85K

52 Week high

$27.24

52 Week high$27.24

52 Week low

$6.92

52 Week low$6.92

XNCR News

TipRanks 6d

Xencor downgraded to Neutral at BofA on long development timelines

As previously reported, BofA downgraded Xencor (XNCR) to Neutral from Buy with a price target of $12, down from $23. The firm sees catalyst flow picking up for...

Analyst ratings

83%

of 12 ratings

Buy

83.3%

Hold

8.3%

Sell

8.3%

People also own

Based on the portfolios of people who own XNCR. This list is generated using Robinhood data, and it’s not a recommendation.